Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Antiviral Therapy
|
July 19, 2005
Sustained CD4 responses after virological failure of protease inhibitor-containing therapy
S G Deeks, R M Grant
JAMA
|
May 15, 1998
Antiretroviral therapy for HIV infection: promises and problems
P A Volberding, S G Deeks
AIDS (London, England)
|
February 24, 2001
Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient
S G Deeks, J N Martin
Lancet (London, England)
|
May 24, 1997
Genotypic-resistance assays and antiretroviral therapy
S G Deeks, D I Abrams
JAMA
|
January 8, 1997
HIV-1 protease inhibitors. A review for clinicians
S G Deeks, M Smith, M Holodniy, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection
S G Deeks, J D Barbour, J N Martin, et al.
AIDS (London, England)
|
July 24, 1998
Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure
S G Deeks, R M Grant, G W Beatty, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 15, 2001
Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate
S G Deeks, P Barditch-Crovo, A Collier, et al.
Genes and Immunity
|
November 4, 2011
Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African-Americans
L Seu, T D Burt, J S Witte, et al.
AIDS (London, England)
|
February 24, 2001
Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes
T J Liegler, M S Hayden, K H Lee, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Antiviral Therapy
|
July 19, 2005
Sustained CD4 responses after virological failure of protease inhibitor-containing therapy
S G Deeks, R M Grant
JAMA
|
May 15, 1998
Antiretroviral therapy for HIV infection: promises and problems
P A Volberding, S G Deeks
AIDS (London, England)
|
February 24, 2001
Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient
S G Deeks, J N Martin
Lancet (London, England)
|
May 24, 1997
Genotypic-resistance assays and antiretroviral therapy
S G Deeks, D I Abrams
JAMA
|
January 8, 1997
HIV-1 protease inhibitors. A review for clinicians
S G Deeks, M Smith, M Holodniy, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection
S G Deeks, J D Barbour, J N Martin, et al.
AIDS (London, England)
|
July 24, 1998
Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure
S G Deeks, R M Grant, G W Beatty, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 15, 2001
Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate
S G Deeks, P Barditch-Crovo, A Collier, et al.
Genes and Immunity
|
November 4, 2011
Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African-Americans
L Seu, T D Burt, J S Witte, et al.
AIDS (London, England)
|
February 24, 2001
Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes
T J Liegler, M S Hayden, K H Lee, et al.
Page
of 5